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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYPluripotent stem cells (PSCs) occupy a spectrum of reversible molecular states ranging from a naive ground-state in 2i, to metastable em-
bryonic stem cells (ESCs) in serum, to lineage-primed epiblast stem cells (EpiSCs). To investigate the role of DNA methylation (5mC)
across distinct pluripotent states, we mapped genome-wide 5mC and 5-hydroxymethycytosine (5hmC) in multiple PSCs. Ground-state
ESCs exhibit an altered distribution of 5mC and 5hmC at regulatory elements and dramatically lower absolute levels relative to ESCs in
serum. By contrast, EpiSCs exhibit increased promoter 5mC coupled with reduced 5hmC, which contributes to their developmental
restriction. Switch to 2i triggers rapid onset of both the ground-state gene expression program and global DNA demethylation. Mecha-
nistically, repression of de novomethylases by PRDM14drives DNAdemethylation at slow kinetics, whereas TET1/TET2-mediated 5hmC
conversion enhances both the rate and extent of hypomethylation. These processes thus act synergistically during transition to ground-
state pluripotency to promote a robust hypomethylated state.INTRODUCTION
Pluripotent stem cells (PSCs) exhibit the core properties of
self-renewal and the capacity to differentiate into all
embryonic lineages. These properties are underpinned by
expression of a core circuitry of pluripotency transcription
factors and reinforced by epigenetic mechanisms (Surani
et al., 2007). Mouse embryonic stem cells (ESCs) are classi-
cally cultured in serum/leukemia inhibitory factor (LIF)
and considered to harbor ‘‘naive’’ pluripotency, which
reflects their unrestricted potential to contribute to all
somatic lineages and the germline in chimeras (Nichols
and Smith, 2009). However, the undefined signaling in
serum conditions means that ESCs exhibit heterogeneous
gene expression profiles and exist in at least two distinct
but interchangeable populations corresponding to a naive
and a more developmentally restricted ‘‘primed’’ state and
are thus termed metastable (Hayashi et al., 2008; Toyooka
et al., 2008).
Recent studies have revealed that inhibition of mitogen-
activated protein kinase kinase (MEK) and glycogen syn-
thase kinase-3 (GSK3) by culture in 2i harnesses ESCs in
an apparently homogeneous naive ‘‘ground-state,’’ which
more closely recapitulates the transcriptional and epige-
netic state of the preimplantation epiblast cells fromwhich
ESCs are derived (Ying et al., 2008;Marks et al., 2012; Leitch
et al., 2013). In contrast, epiblast stem cells (EpiSCs), which
are established from the postimplantation epiblast, occupy
a pluripotent state ‘‘primed’’ toward lineage differentiation,518 Stem Cell Reports j Vol. 1 j 518–531 j December 17, 2013 j ª2013 Thewhich is reinforced by culture with FGF and activin (Brons
et al., 2007; Tesar et al., 2007). An additional PSC type
termed embryonic germ cells (EGCs) can be derived from
primordial germ cells (PGCs). Although PGCs are specified
from primed postimplantation epiblast, EGCs appear to be
transcriptionally and functionally comparable to ESCs and
not to EpiSCs, implying that EGCs undergo reprogram-
ming to a more naive state (Matsui et al., 1992; Leitch
et al., 2010, 2013). Collectively, these mouse PSCs repre-
sent a wide spectrum of pluripotent states that can be
used for investigation of developmental processes
in vitro. Moreover, understanding the molecular determi-
nants of naive pluripotency in mouse ESCs may yield in-
sights toward derivation and benchmarking of bona fide
naive human ESCs (hESCs) (De Los Angeles et al., 2012).
Epigenetic mechanisms including histone modifications
and DNAmethylation play an important role in stabilizing
cell identity and orchestrating many developmental pro-
cesses. DNA methylation (5mC) is associated with tran-
scriptional silencing and is essential for mouse embryonic
development but dispensable for the derivation of ESCs
(Okano et al., 1999). Nonetheless, DNA methylation-defi-
cient ESCs are unable to differentiate, indicating that
5mC is required for exit from pluripotency (Jackson et al.,
2004). Indeed, de novo promoter methylation occurs rela-
tively early during differentiation—at transition to progen-
itor cells rather than upon terminal differentiation—which
may reflect an early and stable ‘‘lock’’ on lineage commit-
ment (Mohn et al., 2008).Moreover, 5mC at key gatekeeperAuthors
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5mC and 5hmC Profiles in Pluripotent Stem Cellsgenes such as Elf5 acts to restrict ESCs to embryonic fates
and prevent their contribution to extraembryonic tissues
(Ng et al., 2008). Notably, metastable ESCs in serum exhibit
relatively high global DNA methylation levels that are
comparable with differentiated tissues, whereas naive
ground-state ESCs exhibit a globally hypomethylated state
(Leitch et al., 2013; Yamaji et al., 2013; Ficz et al., 2013;
Habibi et al., 2013). Thus, the genomic landscape of DNA
methylation may play an important role in defining the
balance between restriction and plasticity in PSCs.
Recent studies have shown that 5mC can be oxidized to
5-hydroxymethycytosine (5hmC) by TET enzymes and
that this process may play a role in global DNA demethyla-
tion during preimplantation development and in the germ-
line (Tahiliani et al., 2009; Iqbal et al., 2011; Hackett et al.,
2013). Conversion of 5mC to 5hmC can potentially
engender both replication-dependent ‘‘passive’’ or replica-
tion-independent ‘‘active’’ demethylation (Hackett et al.,
2012). These pathways could allow turnover or resetting of
DNA methylation to promote and maintain pluripotent
states. Indeed, both 5hmC and TET enzymes are relatively
abundant in PSCs (Ficz et al., 2011; Koh et al., 2011). How-
ever, Tet1/Tet2 null ESCs can be efficiently derived and are
pluripotent (Dawlaty et al., 2013), and thus, any potential
role of 5hmC in promoting dynamic DNA methylation
turnover in the context of each pluripotent state remains
unclear. Indeed, alternative DNA demethylation mecha-
nisms involving suppression of de novo or maintenance
methylation activity have been suggested (Yamaji et al.,
2013; Seisenberger et al., 2012), implying that multiple par-
allelmechanismsmaypromoteDNAdemethylation inPSCs
(Hackett et al., 2012). Importantly, whereas recent studies
have mapped the hypomethylated epigenome of ground-
state ESCs at base resolution (Habibi et al., 2013; Ficz et al.,
2013), they did not distinguish between 5mC and 5hmC.
Moreover, the global profiles of 5mC and 5hmC in the
primed state (EpiSC) and in EGCs remain to be determined,
as do the precisemechanisms that drive interconversion be-
tween distinct DNAmethylation landscapes.
Here, we set out to investigate genome-wide 5mC
and 5hmC in diverse PSCs and found significant changes
associated with distinct pluripotent states. Moreover, we
show that dual TET-mediated 5hmC conversion and
PRDM14-dependent Dnmt3 repression synergistically
drive DNA demethylation during transition to ground-
state pluripotency.RESULTS
Global 5mC and 5hmC in Pluripotent Cells
To investigate the roles and dynamics of 5mC and 5hmC
in PSCs derived fromdistinct developmental origins, or un-Stem Cell Rder different culture conditions, we used five genetically
matched cell types:male XYand female XX ESCs on feeders
in classical serum/LIF media, ground-state ESCs and EGCs
under serum-free 2i/LIF conditions (both XY), and primed
EpiSCs derived from postimplantation epiblast. We first
determined the global levels of 5mC and 5hmC quantita-
tively by ELISA and found that total 5mC levels were highly
comparable among XY ESCs in serum, EpiSCs, and control
mouse embryonic fibroblasts (MEFs). However, 5mC levels
were reduced slightly in XX ESCs and significantly reduced
by 2.2-fold in both ESCs and EGCs maintained in 2i (Fig-
ure 1A). The global levels of 5hmC followed a similar
pattern, with relatively high levels in ESCs in serum and
EpiSCs but reduced levels in cells in 2i. The global reduc-
tion of 5hmC in 2i was comparable in extent to 5mC
(1.9-fold); however, 5hmC is significantly higher in all
PSCs relative to MEFs (Figure 1A). Thus, global 5mC and
5hmC levels are comparable in ESCs in serum and primed
EpiSCs but significantly and proportionately reduced in
ground-state PSCs cultured in 2i, which is consistent with
recent studies (Leitch et al., 2013; Ficz et al., 2013; Habibi
et al., 2013).
To confirm changes in DNA modification, we used
bisulfite sequencing to assay repetitive and single-copy
genomic regions. This revealed that LINE-1 elements,
CpG-dense promoters at Dazl and Rhox9, CpG-poor
promoters at Esrrb and Elf5, an intronic region at Cul1,
and exonic sequences of Rex1 are all significantly hypo-
methylated in ESCs/EGCs in 2i relative to ESCs in serum
or EpiSCs, suggesting that hypomethylation occurs at
most genomic landmarks in 2i (Figure 1B; Figure S1
available online). A notable exception is IAP elements,
which showed no significant difference regardless of the
culture condition (Figure 1B), a result consistent with
IAPs being resistant to DNA hypomethylation in vivo
(Hajkova et al., 2002; Hackett et al., 2013). However, IAPs
did exhibit significantly reduced DNA methylation in XX
ESCs, which is apparently a specific effect because tested
promoter regions and LINE-1 elements were not differ-
entially methylated between our low-passage XX and XY
ESCs, and global levels only showed a modest reduction
in XX ESCs (Figures 1A and 1B). Interestingly, we observed
that XX, but not XY, ESCs exhibited additional global
hypomethylation coincident with transition to feeder-
free culture, while maintaining XX status, implying that
female ESCs may be more susceptible to DNA demethyla-
tion as a consequence of in vitro culture parameters than
male ESCs (Figure S1). In particular, feeder-free culture
may promote global hypomethylation in XX ESCs (Habibi
et al., 2013; Zvetkova et al., 2005). Our data suggest that
PSCs acquire distinct DNAmethylation profiles that reflect
their developmental origin and response to culture
conditions.eports j Vol. 1 j 518–531 j December 17, 2013 j ª2013 The Authors 519
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Figure 1. 5mC and 5hmC Distributions in Distinct Pluripotent States
(A) Global levels of 5mC (blue) and 5hmC (red) in EGCs in 2i (EGC-2i), ESCs in 2i (ESC-2i), male ESCs in serum (ESC-M), female ESCs in serum
(ESC-F), EpiSCs, and MEFs, as a percentage of total nucleotides.
(B) Bisulfite sequencing of repetitive and single-copy loci in distinct PSCs. Open circles represent unmethylated CpGs, and closed circles
represent methylated CpGs.
(C) Hierarchical clustering of PSCs based on genome-wide 5mC and 5hmC distribution.
(D) Correlation coefficients of 5mC and 5hmC between PSCs.
(E) Profile shows the distribution of 5mC and 5hmC over an averaged metagene in each pluripotent state.
(F and G) Profiles of 5mC and 5hmC in PSCs at (F) Esrrb and (G) Dazl. Shaded area indicates promoter region.
**p < 0.01 of biological triplicate experiments.
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Cells
To further investigate the DNA modification landscape
in pluripotent cells, we performed genome-wide methyl-
ated DNA immunoprecipitation sequencing (meDIP-seq)
and hydroxymethylated DNA immunoprecipitation
sequencing (hmeDIP-seq). To facilitate comparison with
(h)meDIP profiles from low-number PGCs, which share
certain attributes of pluripotency and undergo dynamic
DNA demethylation, we used a low-input protocol with a
high-fragment resolution of 150 bp (Hackett et al.,
2013). Hierarchical clustering of DNAmodification profiles
revealed that pluripotent cells cluster into distinct groups
that correspond to ground-state, metastable, or primed
cells (Figure 1C). Indeed, we observed similar clustering520 Stem Cell Reports j Vol. 1 j 518–531 j December 17, 2013 j ª2013 Thebased only on 5mC and 5hmC profiles at binding sites of
key chromatin factors (Figure S1). Consistently, the highest
correlation coefficients were observed between cells within
the same culture condition, regardless of developmental
source, such that ESCs and EGCs derived from the ICM
and PGCs, respectively, were highly comparable in 2i
conditions. In contrast, the greatest difference was seen
between ESCs/EGCs in 2i and EpiSCs, which also corre-
sponds to the biggest difference in developmental poten-
tial (Figure 1D). Consistent with global hypomethylation
under 2i conditions, ESCs in serum were more correlated
with EpiSCs than with ESCs in 2i.
Analysis of 5mC enrichment across a metagene revealed
a comparable distribution in each pluripotent state,
whereby 5mC is enriched within genic regions andAuthors
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5mC and 5hmC Profiles in Pluripotent Stem Cellsstrongly depleted from transcriptional start sites (TSSs) (Fig-
ure 1E). We observed that 5hmC is also depleted from the
TSS but found significant peaks of 5hmC enrichment in
the flanking proximal promoter regions in ESCs in serum
and EpiSCs, which was absent in ground-state cells (Fig-
ure 1E). We did note that 5hmC was enriched at the TSS
specifically at low CpG density promoters but only when
also bound by TET1 (Figure S1). Notably, some studies pre-
viously reported that 5hmC is enriched directly at the TSS
in general but used a 300–500 bp hmeDIP resolution rather
than the 150 bp used here, which may have enabled some
‘‘bridging’’ of the TSS by fragments that also overlapped
flanking promoter/exonic regions enriched in 5hmC (Fig-
ure S2). Examination of specific loci such as the Esrrb
promoter showed that it is highly enriched with 5hmC in
ESCs in serum (XY and XX), as previously reported by
Ficz et al. (2011), and that this is lost in 2i, coincident
with reduction of 5mC (Figure 1F). In contrast, 5hmC
enrichment was maintained at the Dazl promoter in
ground-state cells, which may be due to the retention of
some 5mC signal under 2i conditions. However, there
was a complete loss of 5hmC in primed EpiSCs together
with a concomitant increase in 5mC enrichment
(Figure 1G).
Differential Promoter Methylation
To investigate the genome-wide changes between PSCs, we
examined promoters for differential methylation using XY
ESCs in serum as a reference. A previous study has shown
that feeder-free XX ESCs are globally hypomethylated
(Zvetkova et al., 2005). However, consistent with our obser-
vation of only amodest global depletion (10%) of 5mC in
XXESCs on feeders, we found only 69 high-confidence (p <
0.01) differential 5mC promoters between XX and XY
ESCs. Surprisingly, there were more promoters methylated
in XX ESCs (n = 55) relative to XY ESCs (n = 14), albeit there
were very few differentially methylated promoters (DMPs)
in absolute terms, which suggests that male and female
ESCs share a highly similar promoter methylome, at least
when cultured on feeders (Figure 2A). Comparison of
ESCs in serum with ESCs in 2i revealed 228 high-confi-
dence DMPs, withmost being hypomethylated in 2i condi-
tions (n = 179). Gene ontology (GO) analysis indicated that
promoters hypomethylated in ground-state 2i relative to
serum are not associated with specific processes/pathways
after Bonferroni correction, suggesting that promoter hy-
pomethylation is a general rather than a targeted effect in
2i. Similarly, the few promoters that apparently exhibited
higher 5mC in 2i were not enriched for GO categories but
did apparently include Lin28b, which can promote both
self-renewal and differentiation pathways depending on
context (Shyh-Chang and Daley, 2013). Relatively elevated
DNAmethylation at Lin28b is consistent with lower Lin28bStem Cell Rexpression in 2i (Figure S3) (Marks et al., 2012). Interest-
ingly, rare single-copy loci that escape DNA demethylation
in PGCs, such as Sfi1 and Srrm2 (Hackett et al., 2013), are
also resistant to demethylation in 2i conditions, although
Vmn2r29 is hypomethylated (Figure S3).
Examination of promoter 5mC in EpiSCs revealed a strik-
ing number of promoters (n = 668) that become signifi-
cantly hypermethylated relative to ESCs in serum, with
only 19 exhibiting lower 5mC (Figure 2A). Promoters that
becomemethylated in EpiSCs are highly enriched for being
bivalently or H3K27me3marked in ESCs and includemany
pluripotency and germline-specific genes such as Stella,
Rex1, and Tcl1 (Figures 2B and 2C). In addition to acquisi-
tion of promoter 5mC, these genes often acquire DNA
methylation throughout their entire transcription unit in
EpiSCs, which may be related to stable heterochromatini-
zation of these loci (Figure 2C). In general, when collated,
the DMPs between all PSCs are enriched for an intermedi-
ate CpG density and depleted of CpG-poor promoters
(Figure 2B).
Taken together, this analysis suggests that there is a
general progressive gain of promoter 5mC coincident
with transition from ground state > metastable > primed
states. Notably, the most significant acquisition of pro-
moter 5mC occurs in primed EpiSCs, which is in contrast
to global 5mC, where significant gain occurs between
ground-state ESCs in 2i and ESCs in serum. Thus, in gen-
eral, promoters in ESCs cultured in serum are resistant to
acquiring 5mC despite a high global DNA methylation
context. In contrast, a significant number of promoters
acquire DNA methylation in EpiSCs, coincident with a
constraint on cellular plasticity.
Analysis of differentially hydroxymethylated promoters
(DhMPs) showed that both ground-state cells and primed
EpiSCs were associated with a significantly reduced num-
ber of 5hmC-enriched promoters relative to ESCs in serum
(Figure 2A). The observation that the highest relative num-
ber of 5hmC-enriched promoters occurs in serumESCs is in
contrast to 5mC, where in general, enrichment of methyl-
ated promoters follows a linear pattern that correlates with
increasingly restricted cells (ground state > metastable >
primed). The enhanced promoter 5hmC in ESCs in serum
may contribute to the relative resistance of promoters to
acquiring 5mC, despite the high global 5mC levels. Consis-
tent with this, tracking 5mC and 5hmC at all promoters
across pluripotent states showed that promoter 5mC
enrichment peaks in EpiSCs, whereas 5hmC enrichment
peaks in ESCs in serum, with a similar result at biologically
defined CpG islands (Figure 2D) (Illingworth et al., 2010).
This effect was particularly prominent at pluripotency
network genes, which presumably need to remain methyl-
ation-free in ESCs to ensure robust expression and there-
fore may be enriched in 5hmC (Figure 2E). In contrast,eports j Vol. 1 j 518–531 j December 17, 2013 j ª2013 The Authors 521
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Figure 2. Differentially DNA-Modified Promoters between PSCs
(A) Number of DMPs and DhMPs in PSCs relative to male ESCs in serum. Black bars indicate the number of promoters with higher DNA
modification, and gray bars indicate the lower levels in the indicated cell type.
(B) Genetic and epigenetic features of differentially methylated promoters (DMP). Upper panel shows CpG density and chromatin state of
DMPs that exhibit gain of 5mC between each successive pluripotent state (2i to serum, serum to EpiSC). Promoters that get methylated
between serum ESC and EpiSC states are enriched in being bivalent. Lower panel shows collated CpG density and chromatin state of all
promoters that become significantly differentially (hydroxy)methylated between at least one pairwise PSCs comparison.
(C) Profiles of 5mC and 5hmC at Stella and Tcl1 in PSCs. Shaded area indicates promoter region.
(D and E) Enrichment dynamics of 5mC (blue) and 5hmC (red) by (h)meDIP-seq across ground-state ESCs in 2i, metastable ESCs in serum,
and primed EpiSCs at (D) distinct genomic landmarks or (E) gene network promoters.
Error bars represent SD of target enrichment(s). CGI, biologically defined CpG island.
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5mC and 5hmC Profiles in Pluripotent Stem Cells‘‘primed’’ genes continue to acquire 5hmC in EpiSCs and
remain depleted of 5mC, which may reflect the require-
ment to keep these genes competent for expression in
EpiSCs. Finally, germline-specific genes become robustly
methylated in EpiSCs, which correlates with a dramatic
loss of promoter 5hmC and may ‘‘lock in’’ a silenced state
(Figure 2E). These data indicate a dynamic interplay be-
tween promoter 5mC and 5hmC that may contribute to
the maintenance of each pluripotent state.522 Stem Cell Reports j Vol. 1 j 518–531 j December 17, 2013 j ª2013 TheImprint Stability in PSCs
We next asked how 2i conditions affect genomic imprints,
which are generally resistant to hypomethylation in vivo
and only become demethylated in PGCs. We found that
enrichment of 5mC at imprints was highly comparable be-
tween ESCs in 2i and ESCs in serum, suggesting that they
are resistant to the global hypomethylation in ground-state
cells (Figure 3A) (Leitch et al., 2013). Moreover, imprints
were fully maintained in EpiSCs, with the slight increaseAuthors
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Figure 3. 5mC and 5hmC Enrichment at Genomic Imprints and Enhancers
(A) Box plots show enrichment of 5mC and 5hmC over gametic-imprinted DMRs (n = 21) in PSCs.
(B) Distribution of 5mC and 5hmC over the imprinted Peg10 DMR (gray shading) in PSCs and E11.5 PGCs.
(C) Bisulfite sequencing reveals loss of imprints at Peg3 and Peg10 DMRs in independent early-passage XX ESC lines but imprint main-
tenance in control EpiSCs and XY ESCs.
(D) Clustering of PSCs according to 5mC and 5hmC enrichment at imprinted DMRs. EGCs and XX ESCs (ESC-F) cluster separately from other
PSCs due to erasure of imprints.
(E) Average enrichment of 5hmC at all gametic-imprinted DMRs in PSCs and E11.5 PGCs. 5hmC is enriched specifically in PGCs, where
imprints are in the process of dynamic erasure.
(F) The profiles of 5mC (upper) and 5hmC (lower) over poised enhancers in EGCs and ESCs in 2i, male and female ESCs in serum, and EpiSCs
(G) GluMS-qPCR of quantitative (%) 5mC and 5hmC levels at the Foxo1, Gck, Klf4, and Nanog enhancers in ESCs (XY) cultured in serum or 2i.
Error bars represent SD of biological duplicate experiments. **p < 0.01.
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5mC and 5hmC Profiles in Pluripotent Stem Cellsin 5mC enrichment possibly a consequence of denser DNA
methylationwithin eachmethylated allele in EpiSCs rather
than an increase in allelic methylation. In contrast, we
observed that 5mC was significantly depleted from many
imprints in EGCs in 2i, which reflects their origin from
PGCs (Figures 3A and 3B). We also found imprints to be
almost completely erased in our low-passage female ESCs
(Figures 3A and 3B), which we confirmed in two further in-Stem Cell Rdependent XX ESC lines (Figure 3C). Thus, genomic im-
prints are resistant to the globally hypomethylated state
in 2i conditions, but like EGCs, XX ESCs are highly
disposed to imprint erasure. Indeed, EGCs and XX ESCs
cluster together according to 5mC enrichment of ‘‘im-
prints,’’ whereas EpiSCs and XY ESCs in 2i or serum cluster
separately (Figure 3D). Because our XX ESCs exhibited no
significant loss of promoter 5mC and only a modesteports j Vol. 1 j 518–531 j December 17, 2013 j ª2013 The Authors 523
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5mC and 5hmC Profiles in Pluripotent Stem Cellsreduction in global 5mC, they apparently become hypo-
methylated preferentially at genomic features that are nor-
mally most resistant to DNA demethylation in vivo—IAP
and genomic imprints—through an as yet undetermined
mechanism. Notably, imprints were highly depleted of
5hmC in all cell types, which contrasts with PGCs, which
exhibit highly significant 5hmC enrichment coincident
with imprint erasure (Figure 3E) (Hackett et al., 2013).
Interestingly, EGCs exhibited the greatest enrichment of
5hmC at imprints despite reduced levels of 5mC substrate,
which could be a consequence of their derivation from
PGCs (Figure 3A). However, the low absolute levels of
5hmC at genomic imprints in PSCs, in general (Figures 3
and 2D), likely contribute to their relative resistance to
demethylation in most contexts, including in the globally
hypomethylated state of 2i conditions.
Differential DNA Modifications at Enhancers
We next tested the enrichment of 5mC and 5hmC at en-
hancers in PSCs. Poised enhancers, defined by DNase
I-hypersensitive sites (DNase HSs) and H3K4me1 enrich-
ment in ESCs, were depleted of 5mC but enriched for
5hmC in ESCs in serum, as expected (Figure 3F) (Yu et al.,
2012). In contrast, active enhancers (additionally marked
by H3K27ac) exhibited no enrichment for 5hmC and
remained depleted of 5mC, suggesting that once activated,
enhancers dispense with the 5hmC signature (Figure S3). A
similar profile at enhancers was observed for XX ESCs,
further underscoring the general similarity between XX
and XY ESC methylomes on feeders (excepting imprints
and IAP) (Figure 3F). Interestingly, in contrast to 5hmC
enrichment in serum conditions, poised enhancers ex-
hibited a significant depletion of 5hmC in both ESCs and
EGCs in 2i. Moreover, whereas EpiSCs maintained the
5hmC signature at this enhancer set, it was also associated
with acquisition of 5mC (Figure 3F). These data suggest
that cells in each pluripotent state may utilize or are pre-
marked for the use of distinct enhancer sets, which may
have roles in cellular competence and epigenetic priming
(Song et al., 2013; Shen et al., 2013).
To further investigate distal regulatory elements, we used
glucosyltransferase methylation-sensitive qPCR (GluMS-
qPCR) to examine poised enhancers linked with the Pro-
B cell- and liver-specific genes Foxo1 and Gck, respectively,
and active enhancers linked to the pluripotency genes Klf4
and Nanog (Whyte et al., 2013). We found 5mC levels to be
between 10% and 50% at all these enhancers in ESCs in
serum, consistent with them being low-methylated regions
(LMRs) that are associated with regulatory elements (Fig-
ure 3G) (Stadler et al., 2011). At all enhancers examined,
5mC was reduced 2- to 4-fold in 2i, which is proportion-
ately in line with the global hypomethylation in ground-
state cells. Moreover, consistent with hmeDIP-seq, the524 Stem Cell Reports j Vol. 1 j 518–531 j December 17, 2013 j ª2013 Thepoised Foxo1 and Gck enhancers were highly enriched for
5hmC (>5%) in ESCs in serum, whereas the active Klf4
and Nanog enhancers were relatively depleted (<1%). How-
ever, the enrichment of 5hmC at poised enhancers was
dramatically lost in 2i (>10-fold), to a significantly greater
extent than global 5hmC depletion (Figure 3G). Thus,
5hmC is apparently a specific marker of poised lineage-
specific enhancers in ESCs in serum, but not 2i. The enrich-
ment of 5hmC may be important for resisting the high
de novo methyltransferase activity in serum conditions,
thereby antagonizing accumulation of repressive DNA
methylation at enhancers that need to remain competent
for downstream commitment.
Molecular Events during Transition to Ground-State
Pluripotency
Because of the dramatic DNAhypomethylation in 2i condi-
tions, we next investigated the kinetics of transition from
serum to 2i. We initially shifted ESCs in serum to 2i condi-
tions and tracked gene expression changes. As expected,
naive pluripotency markers such as Prdm14, Esrrb, and
Stella were upregulated upon transfer to 2i, whereas
primed/early differentiationmarkers including Fgf5, Lefty1,
and Bmp4 were strongly downregulated (Figure 4A) (Marks
et al., 2012). We also observed that the de novo methyl-
ation machinery including Dnmt3a, Dnm3b, and Dnmt3L
was rapidly repressed in 2i, whereas maintenance genes
such as Dnmt1 and Uhrf1 exhibited no change or were
upregulated, respectively. Expression levels of Tet1 were
reduced by 2-fold in 2i but remained expressed at very
high overall levels, whereas Tet2 and Tet3 were not signifi-
cantly affected, albeit the latter was expressed at very low
absolute levels. Notably, changes in gene expression
occurred rapidly upon transfer to 2i, with most changes
being comparable to ESCs maintained in 2i (more than
five passages) within 48 hr (Figure 4A).
The rapid transition of a serum ESC gene expression
profile to a profile comparable to 2i conditions prompted
us to examine the kinetics of DNA methylation changes.
We initially used bisulfite sequencing and found that
LINE-1 and the promoters at Dazl, Rhox6/9, and Elf5
showed some loss of DNAmodification at 48 hr with signif-
icant demethylation by 120 hr (Figure 4B). In particular,
Rhox6/9 and Elf5, which are representative of relatively
CpG-dense and CpG-poor promoters, respectively, were
highly hypomethylated after 120 hr in 2i. In contrast, we
observed no significant changes at IAP and the imprinted
Kcnq1ot1 locus, consistent with our observation that these
regions are resistant to demethylation in 2i. We next used
GluMS-qPCR to track quantitative changes of 5mC and
5hmC at a high temporal resolution at genes with CCGG
motifs. We found that Dazl, Rhox6/9, and Asz1 promoters
underwent a slight reduction of 5mC within 24 hr with aAuthors
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Figure 4. Molecular Dynamics during Transition to Ground-State Pluripotency
(A) Gene expression levels in ESCs in serum (FCS) and at 48 and 120 hr and more than five passages after switch to 2i conditions. Shown are
absolute mRNA levels as a proportion of Gapdh.
(B) Bisulfite sequencing shows DNA methylation of ESCs in serum and at 48 and 120 hr after switch to 2i at gene promoters and LINE-1
repeats.
(C) Kinetics of quantitative (%) 5mC and 5hmC levels upon transition of metastable ESCs in serum (FCS) to ground-state pluripotency (2i)
assayed by GluMS-qPCR.
*p < 0.05 and **p < 0.01, paired Student’s t test. Error bars are SD of independent duplicate experiments performed in technical triplicates.
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Figure 5. PRDM14 Can Drive Partial DNA Demethylation
(A) Induction of exogenous Prdm14 (+DOX) in ESCs in serum has significant effects of gene expression. Shown are expression levels at 48
and 120 hr relative to uninduced (DOX) ESCs.
(B) Western blot validates PRDM14 overexpression after DOX treatment and downregulation of DNMT3A and DNMT3B.
(C) Quantitative 5mC and 5hmC levels by GluMS-qPCR during induction of exogenous Prdm14 in ESCs in serum.
(D) Bisulfite sequencing of Dazl and Elf5 from ESCs in serum that have uninduced Prdm14 (DOX), induced Prdm14 for more than five
passages (+DOX), or control uninduced in 2i conditions.
*p < 0.05 and **p < 0.01, paired Student’s t test. Error bars represent SD of biological duplicate experiments performed in technical
triplicates.
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5mC and 5hmC Profiles in Pluripotent Stem Cellsprogressive loss thereafter. In parallel, the quantitative
levels of 5hmC remained at least stable over the first
72 hr, despite the reduction in its obligate 5mC substrate
(Figure 4C). Indeed, we observed that 5hmC levels may
actually increase modestly at these loci, with a peak be-
tween 48 and 72 hr after shift to 2i conditions. Because
there is no known 5hmC maintenance mechanism (Ficz
et al., 2011) and ESCs transferred to 2i replicate normally,
the observation that 5hmC is initially maintained, and
possibly enriched, whereas 5mC is lost suggests that
5hmC is being continually targeted to these loci at an
increasing rate to account for the decreasing level of the
underlying 5mC substrate. Indeed, plotting the ratio of
5hmC:5mC at tested loci demonstrates the relative enrich-
ment of 5hmC at these loci during transition to ground-
state pluripotency (Figure S4). These data suggest that
5hmC turnover and retargeting may play a role in medi-
ating demethylation upon transfer to 2i.
Prdm14 Contributes to DNA Demethylation in
Ground-State ESCs
To further investigate the mechanism that leads to global
hypomethylation in 2i, we thus considered two possibil-526 Stem Cell Reports j Vol. 1 j 518–531 j December 17, 2013 j ª2013 Theities, which may operate synergistically. First, that 5hmC
is targeted to the genome at an increased rate during tran-
sition to ground-state pluripotency, perhaps owing to
changes in chromatin accessibility or enhanced TET
activity, leading to faster turnover of 5mC and an equilib-
rium shift toward hypomethylation. Second, the upregula-
tion of Prdm14 observed in 2i (Figure 4A) leads to a rapid
repression of the de novo methyltransferase machinery,
thereby promoting the passive loss of 5mC owing to ineffi-
cient maintenance (Chen et al., 2003). Indeed, we and
others have recently reported that Prdm14/ ESCs exhibit
higher steady-state DNA methylation at tested loci than
wild-type (Grabole et al., 2013; Yamaji et al., 2013).
To examine whether Prdm14 directly mediates the dy-
namic DNA demethylation effects of transfer to 2i, we
generated ESCs carrying DOX-inducible expression of
Prdm14. Induction of Prdm14 (+DOX) in serum resulted
in downregulation of primed/early differentiationmarkers,
likely due to repression of FGF signaling (Yamaji et al.,
2013; Grabole et al., 2013), and some upregulation of naive
pluripotency markers by 48 hr (Figure 5A). Importantly,
PRDM14 targets Dnmt3a, Dnmt3b, and Dnmt3L all
exhibited significant repression upon DOX treatment,Authors
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Figure 6. TET-Mediated 5hmC Contributes to DNA Demethylation in 2i
(A) Gene expression dynamics of wild-type and Tet1/Tet2 knockout (DKO) ESCs upon transition to ground-state pluripotency normalized to
wild-type and DKO in serum.
(B) Kinetics of 5mC and 5hmC in wild-type and DKO ESCs at 48 and 120 hr andmore than five passages after shift from serum to 2i conditions.
Shown are CpG-dense promoters (Dazl and Rhox6/9), CpG-poor promoters (Capn9 and Esrrb), introns (Cul1), and repeats (LINE-1).
(C) Bisulfite sequencing of Dazl, Elf5, and Rhox9 promoters and LINE-1 in wild-type and DKO ESCs after five passages in 2i conditions.
*p < 0.05, Student’s t test. Error bars are SD of independent duplicate experiments performed in technical triplicates.
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5mC and 5hmC Profiles in Pluripotent Stem Cellssuggesting that the de novo methylation machinery is
impaired upon Prdm14 expression, even in serum condi-
tions (Figures 5A and 5B). Nonetheless, GluMS-qPCR
revealed that whereas there was some DNA demethylation
at Dazl, Asz1, and Rhox6/9 upon Prdm14 overexpression,
the rate and extent were significantly lower than seen
upon transfer to 2i conditions (compare Figure 5Cwith Fig-
ure 4C); this despite 20-fold Prdm14 upregulation
compared with 6-fold in 2i. This observation was
confirmed by bisulfite sequencing (Figure S4). To test
whether Prdm14 could promote demethylation over
extended time periods, we induced Prdm14 for more than
five passages. Under these conditions, we did observe
significant demethylation relative to uninduced (DOX)
at tested loci; however, DNA methylation still remained
at significantly higher levels than in ESCs shifted to 2i (Fig-
ure 5D). This difference between Prdm14 overexpression
and 2i may in part reflect the fact that Dnmt3a, Dnmt3b,
and Dnmt3L are only partially repressed by Prdm14 over-
expression alone but may also be indicative of otherStem Cell RPrdm14-independent DNA demethylation pathways being
operative during transition to ground-state pluripotency.
Because Prdm14/ ESCs retain DNA methylation in 2i
(Leitch et al., 2013; Grabole et al., 2013; Yamaji et al.,
2013), but overexpression of PRDM14 does not fully
recapitulate global hypomethylation, our results suggest
that Prdm14 is necessary but not sufficient to induce a fully
hypomethylated epigenome in ground-state pluripotent
cells.
TET-Mediated 5hmC Contributes to Global
Hypomethylation
We next turned to the role of 5hmC in promoting DNA
demethylation by using Tet1 and Tet2 compound double-
knockout (DKO) ESCs (Dawlaty et al., 2013). Expression
analysis suggested that upon shift to 2i, naive markers
such as Prdm14 and Esrrb showed no significant change
in the rate or extent of upregulation in DKO ESCs relative
to wild-type (Figure 6A). Moreover, Lefty1 and Fgf5 were
both rapidly repressed in control and mutant cells.eports j Vol. 1 j 518–531 j December 17, 2013 j ª2013 The Authors 527
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5mC and 5hmC Profiles in Pluripotent Stem CellsHowever, we did observe that methylation-dependent
genes such asDazl and Asz1were upregulated faster in con-
trol cells as compared to DKO, implying an inhibition of
DNA demethylation at these loci in DKO ESCs (Figure 6A).
To further investigate this, we examined the DNA deme-
thylation dynamics in DKO ESCs. In serum conditions, we
observed no significant difference in DNA methylation
levels between control and DKO ESCs by bisulfite
sequencing. However, upon transfer to 2i, the rate of deme-
thylationwas impaired specifically inDKO cells (Figure S4).
GluMS-qPCR analysis showed that CpG-dense promoters
(Dazl and Rhox6/9), CpG-poor promoters (Esrrb), and exons
(Cul1) all exhibited a delay in the rate of 5mC depletion in
DKO cells, whereas some loci (Capn9) were apparently un-
affected (Figure 6B). As expected, 5hmC was undetectable
in DKO ESCs at all loci, but a peak of quantitative 5hmC
enrichment occurred in wild-type controls at 48 or 120 hr
after shift to 2i. The relative delay of 5mC erasure in DKO
cells was greater than the reported slight proliferation
defect (Dawlaty et al., 2013), suggesting that these results
do not only reflect slower DNA replication in DKO ESCs.
Indeed, importantly, even after more than five passages
in 2i conditions, DKO cells still exhibited significantly
elevated levels of 5mC at multiple loci, suggesting that in
the absence of TET1 and TET2, ESCs are intrinsically
blocked from reaching complete global hypomethylation
(Figure 6B). Bisulfite sequencing confirmed that Dazl,
Elf5, and Rhox6/9 promoters and LINE-1 repeats are all
substantially more methylated in DKO cells relative to
wild-type in 2i, albeit these loci have undergone significant
demethylation relative to serum conditions (Figure 6C).
Collectively, these results support an important role for
TET-mediated 5hmC conversion in enhancing complete
DNA demethylation in ground-state pluripotency. This
likely occurs synergistically with repression of the de
novo methyltransferases, in part by PRDM14, to promote
a robust hypomethylated state.DISCUSSION
Our findings document that discrete pluripotent states—
naive ground state (2i), metastable (serum), and primed—
are each associated with distinct 5mC and 5hmC profiles.
Because these states are interchangeable, culture condi-
tions thus dictate the epigenomic landscape of pluripotent
cells. Notably, culture in 2i directs a globally hypomethy-
lated state, with our genome-wide analysis indicating
that most loci are susceptible to DNA demethylation, as
recently suggested by Ficz et al. (2013) and Habibi et al.
(2013). Exceptions are imprints and IAPs, which in accor-
dance with their resistance to demethylation during preim-
plantation reprogramming, remain methylated in 2i. We528 Stem Cell Reports j Vol. 1 j 518–531 j December 17, 2013 j ª2013 Thefound that in general, 5mC is acquired during progression
from ground-state pluripotency to primed pluripotency.
However, whereas the levels of global 5mC dramatically in-
crease between ESCs in 2i and those in serum, promoters
are relatively resistant to acquisition of 5mC until progres-
sion to the primed state, characterized by EpiSCs. In
contrast, 5hmC is particularly enriched at promoters in
ESCs cultured in serum, which may function to protect
promoter regions from the high global 5mC and de novo
methylase activity in this condition, thus maintaining a
permissive transcriptional state. Consistently, this observa-
tion is particularly prominent at pluripotency-associated
genes. Moreover, poised, but not active, enhancers are
highly enriched for 5hmC specifically in ESCs in serum,
which may function to protect these regions from stable
DNA methylation in the absence of functional activation.
This could potentially maintain their competence to
enable unbiased lineage commitment. Indeed, ESCs
depleted of TET proteins exhibit skewed lineage differenti-
ation (Koh et al., 2011; Dawlaty et al., 2013).
The dual presence of high de novo methylase activity
and high 5hmC activity in ESCs in serum may represent
capture of a unique epigenetic state not present in vivo,
whereby the methylome is reflective of a more advanced
state of differentiation (hypermethylated) but retains
competence for pluripotency through demethylation of
key regulatory elements. Such targeted hypomethylation
(at some enhancers and promoters) may explain the
conundrum that ESCs in serum are associated with high
levels of global DNA methylation normally linked with
lineage restriction but still exhibit the pluripotent proper-
ties of the hypomethylated preimplantation epiblast. In
contrast, the striking global hypomethylation in 2i culture
parallels the naive epiblast in vivo and supports the
paradigm that 2i conditions more faithfully recapitulate
the unrestricted state of the inner cell mass from which
ESCs are derived.
Notably, ESCs in serum can rapidly initiate DNA deme-
thylation upon shift to 2i. Mechanistically, this is founded
upon Prdm14 upregulation driving repression of Dnmt3
genes and TET-mediated conversion to 5hmC. These
processes are likely complementary and shift the equilib-
rium between de novo methylation activity and 5hmC-
mediated demethylation toward hypomethylation. Thus,
upon transition to 2i, Dnmt3 enzymes are repressed, in
part by Prdm14, which suppresses the potential for de
novo DNA methylation activity at the same time as
5hmC activity is at least maintained. This promotes greater
demethylation both independent of 5hmC, through ineffi-
cient maintenance methylation, and via 5hmC, owing to
the absence of cyclical remethylation following 5hmC
conversion. Indeed, it is possible that TET catalytic activity
is actually enhanced in the 2i system either through alteredAuthors
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(Marks et al., 2012), or by a direct effect of culture condi-
tions (Blaschke et al., 2013) because we observed a modest
peak of 5hmC at 48–72 hr after transfer to 2i. In contrast,
the reciprocal transition toward a primed state is associated
with increased de novo activity through upregulation of
Dnmt3 genes and parallel downregulation of Tet1 (Fig-
ure S4), which shifts the equilibrium toward stable 5mC
maintenance.
Knockout of Dnmta3 and Dnmt3b in ESCs leads to pro-
gressive hypomethylation, supporting the notion that de
novo activity is required tomaintain 5mC in ESCs, possibly
to offset persistent 5hmC conversion (Chen et al., 2003).
However, importantly, Dnmt3a/b null ESCs only exhibited
an 10%–20% reduction in global 5mC after five passages
compared with >2-fold in 2i (Jackson et al., 2004; Chen
et al., 2003; Leitch et al., 2013), suggesting that ground-
state conditions must activate additional DNA demethy-
lation processes independent of Dnmt3a/b repression.
Indeed,Tet1/Tet2null ESCs used here exhibit a partial block
to DNA demethylation in 2i conditions, supporting an
important role for 5hmC conversion. Nonetheless, a signif-
icant degree of hypomethylation was still observed in DKO
ESCs, implying that DNA demethylation is not reliant on
5hmC per se. Thus, a dual model may operate whereby
repression of de novo methylation activity is sufficient to
drive hypomethylation at slow kinetics, whereas the pres-
ence of abundant 5hmC activity may enhance both the
rate and the extent of demethylation, particularly at
CpG-dense regions that are preferential TET-binding sites,
such as the Dazl promoter (Williams et al., 2012). Notably,
though, base-resolution data reveal that 5hmC is detect-
able to some extent throughout the ESC genome (Yu
et al., 2012), and thus, 5hmC may play at least a subordi-
nate role in promoting hypomethylation genome wide.
Indeed, we observed a partial suppression of demethyla-
tion at introns (Cul1) and CpG-poor promoters (Elf5, Essrb,
and Capn9) in DKO ESCs in addition to CpG-dense regions
(Dazl and Rhox9). This model of synergistic demethylation
mechanisms is reminiscent of reprogramming phases in
PGCs and the preimplantation embryo, where significant
global 5hmC conversion has been reported, and that coin-
cides with periods of suppressed maintenance and/or de
novo methylation activity (Hackett et al., 2013; Kagiwada
et al., 2013; Iqbal et al., 2011; Pastor et al., 2013).
The functional consequences of global hypomethylation
in 2i conditions are difficult to disentangle from the direct
effects of ground-state pluripotency. However, one possible
outcome is a relaxation on epigenetic barriers imposed by
DNA methylation. For example, hypermethylation of the
Elf5 promoter has been reported to act as an epigenetic
barrier to prevent ESCs in serum from entering into extra-
embryonic lineages (Ng et al., 2008). Because we observedStem Cell Rrapid and dramatic DNA demethylation and activation of
Elf5 expression after switching ESCs to 2i (Figure S4), this
should enable these ESCs to contribute to extraembryonic
tissues and thus be functionally ‘‘totipotent.’’ Indeed, we
found that ESCs carrying a reporter for constitutive-Venus
expression and cultured in 2i robustly contributed to extra-
embryonic tissues and that this property occurred soon
after the switch in culture conditions (unpublished data),
a finding supported by a recent study (Morgani et al.,
2013). Thus, global hypomethylation in 2i may contribute
to generating a less-restricted in vitro state, which is closer
to functional totipotency, possibly through demethylation
of Elf5. Additionally, DNA hypomethylation per se appears
to promote homogeneity among sister cells after ESC
division and may therefore directly promote self-renewal
(Jasnos et al., 2013).
In summary, we have established the 5mC and 5hmC
profiles of distinct PSCs and revealed that DNA demethy-
lation during transition to ground-state pluripotency
is directed by synergistic TET-mediated 5hmC and
PRDM14-directed repression of Dnmt3a/Dnmt3b/Dnmt3L.
The globally hypomethylated state of cells in 2i may be
an in vitro correlate to the preimplantation epiblast or
migrating PGCs, and thus, transfer to 2i conditions may
provide a tractable system for mechanistic studies into
developmental epigenetic transitions.EXPERIMENTAL PROCEDURES
Cell Lines and Culture Conditions
Animal studies were authorized by a UK Home Office Project
License and carried out in a Home Office-designated facility. Cell
lines used for (h)meDIP-seq profiling were derived from embryos
generated from crossing mixed background Oct4DPE-GFP trans-
genic males with 129SvEv strain females and cultured as follows.
For 2i culture, cells were maintained on laminin (10 mg/ml) in
N2B27 basal media supplemented with 1 mMPD0325901 (MEK in-
hibitor), 3 mM CHIR99021 (GSK3 inhibitor), and LIF at 10 mg/ml
(prepared in house). For serum conditions, cells were maintained
on a MEF feeder layer in DMEM-F12 (GIBCO) supplemented
with 15% FCS, 0.1 mM MEM nonessential amino acids, 2 mM
L-glutamine, 1 mM sodium pyruvate, 0.1 mM b-mercaptoethanol,
and LIF at 10 mg/ml. Cells were passaged by dissociation with
trypsin and replating every 2–3 days. Prior to (h)meDIP-seq
analysis, cells were purified from feeders by sequential preplating
for 2 3 45 min. For primed conditions, EpiSCs were maintained
on fibronectin in DMEM-F12 with N2 and B27 supplement
(Invitrogen) media with 2 mM L-glutamine, 0.1 mMMEM nones-
sential amino acids, 0.1 mM b-mercaptoethanol, 50 mg/ml BSA,
supplemented with recombinant human activin A (20 ng/ml;
PeproTech), and bFGF (12 ng/ml; Invitrogen). EpiSCs were
passaged and replated using Accutase (PAA) every 1–2 days. For
serum to 2i transfer experiments, feeder-free ESCs were derived
on gelatin in GMEM supplemented with 15% FCS, 0.1 mM MEMeports j Vol. 1 j 518–531 j December 17, 2013 j ª2013 The Authors 529
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5mC and 5hmC Profiles in Pluripotent Stem Cellsnonessential amino acids, 2 mM L-glutamine, 1 mM sodium pyru-
vate, 0,1 mM b-mercaptoethanol, 100 U/ml penicillin/100 mg/ml
streptomycin, and LIF at 10 mg/ml and shifted to N2B27 supple-
mented with 1 mM PD0325901, 3 mM CHIR99021, 1% knockout
serum replacement (KSR), and 10 mg/ml LIF on fibronectin. Upon
switching to 2i, cells were passaged every 2–3 days by dissociation
with TrypLE with no obvious effects on cell viability or the ex-
pected proliferation rate.
(h)meDIP-Seq, Bisulfite Sequencing, and GluMS-qPCR
Genome-wide (h)meDIP-seq, bisulfite sequencing, and GluMS-
qPCR were performed as described (Hackett et al., 2013). Full
experimental procedures are detailed in the Supplemental Experi-
mental Procedures.
ACCESSION NUMBERS
Sequencing data have been deposited in the Sequence Read
Archive under accession number SRA111995.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and four figures and can be found with this article
online at http://dx.doi.org/10.1016/j.stemcr.2013.11.010.
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